US AND INTERNATIONAL OPTIONS
BioGX has been on the forefront of COVID-19 testing, using its deep expertise with RNA virus tests – including human/avian/swine influenza and MERS-coronavirus – to develop our initial COVID-19 test.
Complete test in one tube
Capacity of 100,000 tests daily
BioGX offers a complete portfolio of COVID-19 tests for use around the world, each using its Sample-Ready™ approach combining all necessary reagents – mixed and lyophilized – in one tube and ready to run on the platform of your choice.